MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2017 International Congress

    Development and validation of diagnostic criteria for advanced Parkinson disease: the CDEPA questionnaire

    M.-R. Luquin, J. Kulisevsky, P. Martinez-Martin, P. Mir, E. Tolosa, P. Garcia-Delgado (Pamplona, Spain)

    Objective: Using the Delphi methodology we previously obtained a consensus on the definition and clinical characteristics of advanced Parkinson’s disease (APD). We aimed to develop…
  • 2017 International Congress

    Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores

    M. Leehey, S. Luo, S. Sharma, A.-M. Wills, J. Bainbridge, D. Simon, J. Schneider, Y. Zhang, A. Pérez, R. Dhall, C. Christine, C. Singer, F. Cambi (Aurora, CO, USA)

    Objective: To explore the association between metabolic syndrome and Unified Parkinson Disease Rating Scale (UPDRS) scores.  Background: While studies suggest that metabolic syndrome increases the…
  • 2017 International Congress

    Segregation of subjective and objective clinical measures in Parkinson’s disease

    K. Markopoulou, R. Frigerio, A. Premkumar, B. Schoneburg, M. Dudek, S. Walters, C. Wang, D. Maraganore (Evanston, IL, USA)

    Objective: Use standardized measures to characterize disease severity, progression, and outcomes in Parkinson’s disease (PD). Background: Subjective and objective standardized measures are usually performed in…
  • 2017 International Congress

    Development of a Paroxysmal Movement Disorder Diary for Patients with Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

    R. Hall, S. Kilgariff, P. Collins, M. Brandabur, R. Arbuckle, A. Bowden (Macclesfield, United Kingdom)

    Objective: To perform qualitative research to develop and establish content validity of a new clinical outcome assessment (COA) instrument for paroxysmal movement disorders in Glut1…
  • 2017 International Congress

    Item Response Theory Analysis of the MDS-UPDRS Items

    G. Stebbins, C. Goetz, Y. Liu, S. Luo (Chicago, IL, USA)

    Objective: To investigate the measurement characteristics of the MDS-UPDRS using item response theory (IRT) approaches. Background: The MDS-UPDRS has become the most frequently used assessment…
  • 2017 International Congress

    Assessments of Movement Disorder Symptoms and Functional Impacts in Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

    A. Bowden, S. Blair, K. Wesdock, M. Haller, M. Brandabur, P. Collins, A. Skrinar, J. Mayhew (Novato, CA, USA)

    Objective: To identify Clinical Outcome Assessments (COAs) appropriate for the evaluation of paroxysmal movement disorder symptoms and functional impact in Glut1 DS. Background: Glut1 DS…
  • 2017 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)

    S. Luo, G. Stebbins, Y. Liu, C. Goetz (Houston, TX, USA)

    Objective: Test if differential item functioning (DIF) due to gender, age, race/ethnicity or education level is present in UDysRS items.    Background: Testing a rating…
  • 2017 International Congress

    Using measurements from wearable sensors for automatic scoring of Parkinson’s disease motor states

    I. Thomas, F. Bergquist, R. Constantinescu, D. Nyholm, M. Senek, M. Memedi (Falun, Sweden)

    Objective: The aim of this study was to investigate the concurrent validity of an objective gait measure for assessment of motor states in advanced Parkinson’s…
  • 2017 International Congress

    The 3-step clinical prediction tool for falls in Parkinson’s disease: can it be used as a self-assessment measure?

    L. Mewburn, N. Allen, R. Adams, C. Canning (Lidcombe, Sydney, Australia)

    Objective: To determine if people with Parkinson’s disease (PD) are able to estimate their gait speed relative to a threshold speed of 1.1 m/s. Background:…
  • 2017 International Congress

    PDSS: A Novel Mobile-based Parkinson Disease Severity Score

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To propose a novel mobile-based Parkinson Disease Severity Score (PDSS) to provide high resolution and objective severity monitoring for patients in the home setting.…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley